Delivery Order SPE2DB22D2206-SPE2DB25FFR13

Award Date 2/14/25
Potential Completion Date 3/10/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with a ceiling value of $4,917.64. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $1,229.41 for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 4, 2025. The contract is a firm-fixed-price arrangement and does not utilize any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $4,753.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract is a Firm Fixed Price Delivery Order with a completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $10,695.06 Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.70 firm-fixed-price delivery order is for the supply of the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,376.70 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the specialty medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a period of performance through November 2024. AmerisourceBergen, a for-profit organization, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, with a ceiling value of $3,688.23 and a completion date of February 19, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The $2,376.70 firm fixed price delivery order contract has a period of performance through December 4, 2024 and was awarded on November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award, valued at $7,376.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through November 2026. The contract covers the procurement of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,458.82, is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order, with a completion date of February 20, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFR13
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication, and has a ceiling value of $2,458.82.

The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/16/25, 12:03 PM